176 related articles for article (PubMed ID: 22577920)
1. Successful perioperative management of a patient with C1 esterase inhibitor deficiency with a novel bradykinin receptor B2 antagonist.
Senaratne KT; Cottrell AM; Prentice RI
Anaesth Intensive Care; 2012 May; 40(3):523-6. PubMed ID: 22577920
[TBL] [Abstract][Full Text] [Related]
2. Bradykinin B2 receptor antagonist off label use in short-term prophylaxis in hereditary angioedema.
Angeletti C; Angeletti PM; Mastrobuono F; Pilotti L; Ciccozzi A; Guetti C
Int J Immunopathol Pharmacol; 2014; 27(4):653-9. PubMed ID: 25572747
[TBL] [Abstract][Full Text] [Related]
3. Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.
Firinu D; Barca MP; Serusi L; Lorrai MM; Peralta MM; Manconi PE; Del Giacco SR
Int J Immunopathol Pharmacol; 2012; 25(1):269-73. PubMed ID: 22507340
[TBL] [Abstract][Full Text] [Related]
4. Icatibant as acute treatment for hereditary angioedema in adults.
Farkas H
Expert Rev Clin Pharmacol; 2016 Jun; 9(6):779-88. PubMed ID: 27123689
[TBL] [Abstract][Full Text] [Related]
5. First report of icatibant treatment in a pregnant patient with hereditary angioedema.
Farkas H; Kőhalmi KV; Veszeli N; Tóth F; Varga L
J Obstet Gynaecol Res; 2016 Aug; 42(8):1026-8. PubMed ID: 27093898
[TBL] [Abstract][Full Text] [Related]
6. [Hereditary angioedema due to C1-esterase inhibitor deficiency : novel approaches].
Stehlin F; Ribi C
Rev Med Suisse; 2020 Apr; 16(689):675-678. PubMed ID: 32270933
[TBL] [Abstract][Full Text] [Related]
7. Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor.
Prescrire Int; 2010 Nov; 19(110):245-7. PubMed ID: 21284353
[TBL] [Abstract][Full Text] [Related]
8. The Incidence and Frequency of Various Causes of Angioedema in Emergency Medicine.
Karadža-Lapić L; Pikivaca T; Pervan P; Jović Zlatović J; Delin S; Prkačin I
Acta Med Acad; 2018 May; 47(1):11-17. PubMed ID: 29957967
[TBL] [Abstract][Full Text] [Related]
9. Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.
Farkas H; Reshef A; Aberer W; Caballero T; McCarthy L; Hao J; Nothaft W; Schranz J; Bernstein JA; Li HH
J Allergy Clin Immunol Pract; 2017; 5(6):1671-1678.e2. PubMed ID: 28601641
[TBL] [Abstract][Full Text] [Related]
10. Nanofiltrated C1-esterase-inhibitor in the prophylactic treatment of bradykinin-mediated angioedema.
Greve J; Hahn J; Nordmann M; Schuler PJ; Bas M; Hoffmann TK; Hajdu Z; Buchberger M; Strassen U
Transfusion; 2016 May; 56(5):1022-9. PubMed ID: 26756974
[TBL] [Abstract][Full Text] [Related]
11. The Icatibant Outcome Survey: experience of hereditary angioedema management from six European countries.
Caballero T; Aberer W; Longhurst HJ; Maurer M; Zanichelli A; Perrin A; Bouillet L; Andresen I;
J Eur Acad Dermatol Venereol; 2017 Jul; 31(7):1214-1222. PubMed ID: 28370444
[TBL] [Abstract][Full Text] [Related]
12. Effect of bradykinin receptor antagonism on ACE inhibitor-associated angioedema.
Straka BT; Ramirez CE; Byrd JB; Stone E; Woodard-Grice A; Nian H; Yu C; Banerji A; Brown NJ
J Allergy Clin Immunol; 2017 Jul; 140(1):242-248.e2. PubMed ID: 27913306
[TBL] [Abstract][Full Text] [Related]
13. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.
Bouillet L; Boccon-Gibod I; Launay D; Gompel A; Kanny G; Fabien V; Fain O;
Immun Inflamm Dis; 2017 Mar; 5(1):29-36. PubMed ID: 28250922
[TBL] [Abstract][Full Text] [Related]
14. Hereditary angioedema--therapies old and new.
Morgan BP
N Engl J Med; 2010 Aug; 363(6):581-3. PubMed ID: 20818894
[No Abstract] [Full Text] [Related]
15. Icatibant.
Dubois EA; Cohen AF
Br J Clin Pharmacol; 2010 May; 69(5):425-6. PubMed ID: 20573077
[No Abstract] [Full Text] [Related]
16. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.
Cicardi M; Banerji A; Bracho F; Malbrán A; Rosenkranz B; Riedl M; Bork K; Lumry W; Aberer W; Bier H; Bas M; Greve J; Hoffmann TK; Farkas H; Reshef A; Ritchie B; Yang W; Grabbe J; Kivity S; Kreuz W; Levy RJ; Luger T; Obtulowicz K; Schmid-Grendelmeier P; Bull C; Sitkauskiene B; Smith WB; Toubi E; Werner S; Anné S; Björkander J; Bouillet L; Cillari E; Hurewitz D; Jacobson KW; Katelaris CH; Maurer M; Merk H; Bernstein JA; Feighery C; Floccard B; Gleich G; Hébert J; Kaatz M; Keith P; Kirkpatrick CH; Langton D; Martin L; Pichler C; Resnick D; Wombolt D; Fernández Romero DS; Zanichelli A; Arcoleo F; Knolle J; Kravec I; Dong L; Zimmermann J; Rosen K; Fan WT
N Engl J Med; 2010 Aug; 363(6):532-41. PubMed ID: 20818888
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic agents for hereditary angioedema.
Giavina-Bianchi P; Motta A; Kalil J
N Engl J Med; 2011 Jan; 364(1):85; author reply 86. PubMed ID: 21208116
[No Abstract] [Full Text] [Related]
18. Perioperative course in patients with hereditary or acquired angioedema.
MacBeth LS; Volcheck GW; Sprung J; Weingarten TN
J Clin Anesth; 2016 Nov; 34():385-91. PubMed ID: 27687418
[TBL] [Abstract][Full Text] [Related]
19. [Prophylactic use of icatibant before tracheal intubation of a patient with hereditary angioedema type III. (A literature review of perioperative management of patients with hereditary angioedema type III)].
Iturri Clavero F; González Uriarte A; Tamayo Medel G; Gamboa Setién PM
Rev Esp Anestesiol Reanim; 2014; 61(7):375-81. PubMed ID: 24931134
[TBL] [Abstract][Full Text] [Related]
20. Bradykinin-mediated diseases.
Kaplan AP
Chem Immunol Allergy; 2014; 100():140-7. PubMed ID: 24925394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
